Lupine Publishers Current Trends in Gastroenterology and Hepatology

Giant Colonic Lipomas: Diagnostic Accuracy, Case Series and A Review of the Literature by Akingboye AA in Current Trends in Gastroenterology and Hepatology in Lupine publishers Colonic lipomas (CL) are generally asymptomatic and are found incidentally during colonoscopy, colonography or surgery for other conditions. Symptoms often correlate with the size of the lipoma; lipomas larger than 4 cm in size become symptomatic in 75% of patients and they are described as Giant colonic lipoma (GCL). GCL may cause bleeding, obstruction, mimic large polyps, and can create a diagnostic dilemma. We review the clinical management of a series of four GCL patients. https://lupinepublishers.com/gastroenterology-hepatology-journal/fulltext/giant-colonic-lipomas-diagnostic-accuracy-case-series-and-a-review-of-the-literature.ID.000113.php  https://lupinepublishers.com/gastroenterology-hepatology-journal/pdf/CTGH.MS.ID.000113.pdf https://lupinepublishers.com/gastroenterol

Advanced Hepatocellular Carcinoma in A ScottishPopulation – Current Experience and the Future by Baxter MA in Current Trends in Gastroenterologyand Hepatology in Lupine Publishers Sorafenib is the current first line standard of care in patients with advanced hepatocellular carcinoma (HCC). Several other drugs are emerging as efficacious agents in this setting. This article will outline our current real-world experience with sorafenib in a Scottish population as well as discuss the evidence behind new potential therapies in Lupine Publishers. For more information, please go through the below links https://lupinepublishers.com/gastroenterology-hepatology-journal/fulltext/advanced-hepatocellular-carcinoma-in-a-scottish-population-current-experience-and-the-future.ID.000112.php https://lupinepublishers.com/gastroenterology-hepatology-journal/pdf/CTGH.MS.ID.000112.pdf https://lupinepublishers.com/gastroenterology-hepatology-journal/abstracts/advanced-hepatocellular-carcinoma-

New Possibilities of Diagnostics of Non-Alcoholic Fatty Liver Disease by Pirogova I Yu in Current Trends in Gastroenterology and Hepatology in Lupine Publishers The aim of the study was to create a non-invasive model for diagnosing fibrosis and steatosis in non-alcoholic fatty liver disease. Materials and methods. The study included 183 patients with liver steatosis according to ultrasound of the liver. General clinical examination, verification of the stage of fibrosis and steatosis of the liver on the Fibroscan 502 TOUCH device with the CAP software was carried out. Results of the study. Fibrosteatotest ©, based on stigmas of inflammation activity, insulin resistance, lipid spectrum for the diagnosis of fibrosis and steatosis (diagnostic accuracy of more than 80% compared to the results of fibroscanning), is created by the method of discriminant analysis, which allows to identify patients with the 2nd and more stage of fibrosis and steatosis of the liver, who need medica